Mucolytic Comparison Tool
Drug | Mechanism | Typical Dose | Onset (min) | Side Effects | Cost (£/30 days) |
---|---|---|---|---|---|
Carbocisteine | Breaks disulfide bonds in mucus proteins | 750 mg three times daily | 30–60 | Nausea, mild rash | 4.50 |
Acetylcysteine | Reduces mucin cross-linking, antioxidant | 600 mg two to three times daily | 15–30 | Bad taste, bronchospasm (inhaled form) | 5.20 |
Ambroxol | Stimulates surfactant, enhances ciliary activity | 30 mg three times daily | 20–40 | Dry mouth, dizziness | 3.80 |
Bromhexine | Depolymerises mucus, reduces viscosity | 8 mg three times daily | 20–45 | Gastro-intestinal upset | 2.90 |
Guaifenesin | Increases airway fluid, thins mucus | 200–400 mg every 4 h (max 2.4 g/day) | 45–90 | Headache, nausea | 1.60 |
Recommended Mucolytic Based on Your Selection
Key Takeaways
- Carbocisteine is a mucolytic that thins mucus by breaking disulfide bonds, making it easier to cough up.
- Common alternatives - acetylcysteine, ambroxol, bromhexine, and guaifenesin - differ in mechanism, onset, and side‑effect profile.
- For chronic bronchitis and COPD, carbocisteine and ambroxol show the most consistent symptom relief.
- Guaifenesin is cheaper but works slower and is less effective for thick mucus.
- Cost, dosing frequency, and tolerability are the three biggest factors when picking a mucolytic.
What Is Carbocisteine a synthetic mucolytic that reduces the viscosity of sputum by cleaving disulfide bonds in mucoproteins?
Carbocisteine belongs to the class of mucolytics often prescribed for chronic respiratory conditions where thick mucus hampers breathing. In the UK it’s available as a syrup, tablet, or granule, typically taken three times a day for adults.
How Carbocisteine Works
The drug’s active ingredient modifies the structure of mucin polymers, lowering the elasticity of mucus. This action speeds up clearance without irritating the airway, which is why it’s favored for long‑term management of COPD and chronic bronchitis.
When to Use Carbocisteine
Guidelines suggest carbocisteine for patients who experience:
- Frequent productive cough lasting more than three months a year.
- Difficulty clearing sputum during a cold or flare‑up of COPD.
- Recurrent bronchial infections where thick mucus promotes bacterial growth.
It’s not a first‑line option for acute upper‑respiratory infections because its effect builds up over days.

Comparing Common Alternatives
Below is a side‑by‑side look at the most widely used alternatives. The table includes each drug’s mechanism, typical adult dose, usual onset of action, most common side effects, and an approximate NHS price per 30‑day supply (2025 data).
Drug | Mechanism | Typical Adult Dose | Onset (min) | Common Side Effects | Avg. UK Cost (30days) |
---|---|---|---|---|---|
Carbocisteine | Breaks disulfide bonds in mucus proteins | 750mg three times daily | 30-60 | Nausea, mild rash | £4.50 |
Acetylcysteine | Reduces mucin cross‑linking, antioxidant | 600mg two to three times daily | 15-30 | Bad taste, bronchospasm (inhaled form) | £5.20 |
Ambroxol | Stimulates surfactant, enhances ciliary activity | 30mg three times daily | 20-40 | Dry mouth, dizziness | £3.80 |
Bromhexine | Depolymerises mucus, reduces viscosity | 8mg three times daily | 20-45 | Gastro‑intestinal upset | £2.90 |
Guaifenesin | Increases airway fluid, thins mucus | 200‑400mg every 4h (max 2.4g/day) | 45-90 | Headache, nausea | £1.60 |
Acetylcysteine
Acetylcysteine acts as a mucolytic and antioxidant, breaking down mucus while also replenishing glutathione levels in the lungs. It’s available both as an oral tablet and as an inhalation solution for hospitals. The inhaled form can cause temporary bronchospasm, so patients with asthma need close monitoring.
Because it works faster than carbocisteine (onset as short as 15minutes), it’s a good choice for acute exacerbations of COPD, but the taste can be off‑putting for long‑term use.
Ambroxol
Ambroxol enhances surfactant production and stimulates ciliary beat frequency, helping the lungs clear mucus more efficiently. Its relatively low dose (30mg) and twice‑daily schedule make adherence easier. Studies in European cohorts show ambroxol reduces cough frequency by about 30% after two weeks of therapy.
Side effects are mild; the most reported is a dry mouth that usually resolves after a week.
Bromhexine
Bromhexine depolymerises mucus glycoproteins, decreasing viscosity and improving expectoration. It’s often combined with antibiotics in the UK to treat productive bronchitis. The drug’s main drawback is its need for three daily doses, which can be inconvenient for working adults.
Gastro‑intestinal upset is the most common complaint, but taking it with food reduces the issue.
Guaifenesin
Guaifenesin is an expectorant that increases airway fluid, thinning secretions so they can be cleared more easily. It’s sold over‑the‑counter in many countries and is the cheapest option on the table.
However, its slower onset (up to 90minutes) and modest efficacy make it best suited for occasional colds rather than chronic conditions.

Choosing the Right Mucolytic
When you compare the five agents, three decision levers usually dominate:
- Clinical need: Is the goal short‑term relief during an acute flare, or long‑term management of COPD?
- Side‑effect tolerance: Do you mind a metallic taste (acetylcysteine) or occasional dryness (ambroxol)?
- Cost and dosing frequency: Lower price and once‑daily dosing improve adherence.
For chronic bronchitis patients who need consistent mucus thinning, carbocisteine or ambroxol are the top picks. If you need fast relief during a COPD exacerbation, acetylcysteine’s rapid action is valuable-provided you can manage the taste. Guaifenesin works for occasional colds when budget is the primary concern.
Cost and Availability in the UK (2025)
All five drugs are listed on the NHS formulary, but prescription‑only status varies:
- Carbocisteine, ambroxol, and bromhexine require a prescription.
- Acetylcysteine is prescription‑only in oral form but the inhaled version is hospital‑stocked.
- Guaifenesin is available OTC in pharmacies and supermarket aisles.
Average out‑of‑pocket expenses for a 30‑day supply (including prescription fees) are shown in the table above. Prices are subject to regional variations, but the ranking remains consistent: guaifenesin <£2 Each mucolytic carries its own safety profile. Below is a quick cheat‑sheet: Pregnant or breastfeeding women should consult a GP before using any mucolytic, though carbocisteine and ambroxol are generally considered low‑risk. If you need a reliable, long‑term mucus‑thinner for chronic respiratory disease, Carbocisteine remains a solid, cost‑effective choice in the UK. For faster relief during an acute flare‑up, acetylcysteine or ambroxol may be preferable, while guaifenesin serves well for occasional coughs when price is the priority. Always discuss with a healthcare professional to tailor the therapy to your specific condition and lifestyle. Carbocisteine works by breaking disulfide bonds in mucus proteins, which reduces viscosity without causing the irritation that some other agents (like acetylcysteine) can produce. This makes it suitable for long‑term daily use in chronic bronchitis and COPD. Yes, carbocisteine can safely be combined with short‑acting or long‑acting bronchodilators. The two drugs act on different pathways - carbocisteine thins mucus while bronchodilators relax airway muscles - so they complement each other. In the UK carbocisteine syrup is licensed for children aged 6months and older, but the dose is weight‑based and must be prescribed by a pediatrician. Always follow the doctor’s instructions carefully. Most patients notice a reduction in cough intensity within 30‑60minutes, with maximum effect after several days of consistent dosing. Because carbocisteine requires a prescription, you’ll need to see a GP to make the change. The doctor will assess your medical history and decide if the switch is appropriate.Potential Side Effects & Interactions
Bottom Line
Frequently Asked Questions
What makes carbocisteine different from other mucolytics?
Can I take carbocisteine together with a bronchodilator?
Is carbocisteine safe for children?
How quickly will I feel relief after taking carbocisteine?
Can I switch from guaifenesin to carbocisteine without a doctor?
Michelle Abbott
October 9, 2025 AT 23:56From a pharmacodynamic perspective, carbocisteine's disulfide‑bond cleavage offers a quantifiable reduction in sputum viscoelasticity, yet the therapeutic index remains marginal compared to the oxidative mechanisms of N‑acetylcysteine.
Heather Jackson
October 11, 2025 AT 13:53Honestly i feel like the table could've used a lil more colour palette, it just looks like a boring spreadsheet, u know?
Akshay Pure
October 13, 2025 AT 04:46While the exposition delineates mechanistic nuances, one must acknowledge the epistemic hierarchy wherein acetylcysteine's rapid onset supersedes carbocisteine's incremental benefits, rendering the latter a subordinate adjunct in acute management protocols.
Steven Macy
October 14, 2025 AT 18:16It’s worth reflecting on how patient adherence often hinges on dosing frequency; three times a day can be a real hurdle, especially when juggling work and daily responsibilities.
Matt Stone
October 16, 2025 AT 07:46Carbocisteine works but if you want fast relief grab acetylcysteine.
Joy Luca
October 17, 2025 AT 21:16When evaluating mucolytic agents for sustained therapeutic outcomes, one must integrate pharmacokinetic parameters with patient‑centred considerations. Carbocisteine demonstrates a moderate absorption profile, achieving peak plasma concentrations within 1‑2 hours post‑dose. Its half‑life approximates 2‑3 hours, necessitating thrice‑daily administration to maintain effective mucus‑modifying concentrations. The mechanism via disulfide bond disruption yields a gradual attenuation of mucus viscosity, which aligns with chronic bronchitis management where incremental improvement is acceptable. Comparative data indicate that ambroxol, albeit at a lower milligram dose, may potentiate surfactant secretion, offering an adjunctive enhancement of mucociliary clearance. However, ambroxol’s side‑effect profile is dominated by xerostomia, a symptom most patients tolerate. Bromhexine, though cost‑effective, requires strict adherence to three daily doses, and its gastrointestinal irritability can compromise compliance. Acetylcysteine’s rapid onset, documented at 15‑30 minutes, positions it as the agent of choice for acute exacerbations, yet the organoleptic bitterness often reduces long‑term adherence. Guaifenesin’s inexpensive status is attractive, but its pharmacodynamic lag of up to 90 minutes diminishes utility in severe mucus hypersecretion. From a health‑economics standpoint, carbocisteine’s price point (£4.50 per 30‑day supply) situates it between the premium of acetylcysteine and the budget‑friendly guaifenesin, providing a balanced cost‑effectiveness ratio. In clinical practice, titrating the dose to patient weight and renal function may further refine efficacy while mitigating adverse events. Moreover, co‑administration with adequate hydration can amplify mucolytic activity across all agents. Ultimately, the selection algorithm should weigh onset speed, side‑effect tolerance, dosing convenience, and fiscal impact to personalize therapy for each patient.
Jessica Martins
October 19, 2025 AT 10:46The comprehensive overview you provided really helps clinicians weigh the pros and cons, especially when considering patient compliance.
Doug Farley
October 21, 2025 AT 00:16Wow, another boring drug list.